Rallis Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 14-12-2024
- Paid Up Capital ₹ 0.10 M
as on 14-12-2024
- Company Age 14 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Revenue %
(FY 2022)
- Profit -5.05%
(FY 2022)
- Ebitda 61.22%
(FY 2022)
- Net Worth
- Total Assets 4.64%
(FY 2022)
About Rallis Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Sachin Dokania and Ranjit Dokania serve as directors at the Company.
- CIN/LLPIN
U51397BR2010PTC015419
- Company No.
015419
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Mar 2010
- Date of AGM
30 Aug 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Patna
Industry
Company Details
- Location
Patna, Bihar, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Rallis Pharma?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sachin Dokania  | Managing Director | 12-Mar-2010 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ranjit Dokania | Director | 12-Mar-2010 | Current |
Financial Performance of Rallis Pharma.
Rallis Pharma Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a slight decrease in profitability, with a 5.05% decrease in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth | |||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Rallis Pharma?
In 2021, Rallis Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Nexgen Lifestyle Private LimitedActive 11 years 6 monthsSachin Dokania and Ranjit Dokania are mutual person
- Videh Voluntary Institution For Development Education And HopeActive 12 years 11 months
Sachin Dokania and Ranjit Dokania are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Rallis Pharma?
Unlock and access historical data on people associated with Rallis Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rallis Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rallis Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
